Rheumatoid arthritis (RA) is a chronic autoimmune disorder of unknown etiology. Studies indicate that RA is related to the oxidative damage caused by reactive oxygen species, but results have been inconsistent. The aim of this study is to measure the oxidant levels (xanthine oxidase and malondialdehyde) and antioxidant levels (enzymatic superoxide dismutase, catalase and nonenzymatic vitamin E) in the serum and synovial fluid of RA patients. Serum and synovial fluid samples from 146 patients (68 males and 78 females) with active RA and serum samples from 136 healthy volunteers (65 males and 71 females) set as control were collected. The level of oxidants and antioxidants were measured. RA patients had significantly higher mean serum xanthine oxidase and malonaldehyde levels, while levels of superoxide dismutase, catalase and vitamin E were significantly lower when compared to control. Female RA patients had significantly higher serum and synovial fluid xanthine oxidase and malonaldehyde levels when compared to their male counterparts but significantly lower serum and synovial fluid SOD levels.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic progressive inflammatory autoimmune disorder that primarily affects the joints causing joint swelling, stiffness, pain, increased morbidity, and increased mortality with multi-systemic manifestation [1, 2] . RA is classified as a type III hypersensitivity disorder of unknown etiology affecting 1-2% of the population, predominantly women of all age groups and hormonal statuses [3] .
Despite the controversy around its etiology, it is well recognized that RA principally affects the synovium causing chronic hypertrophic 
Sample collection and preparation
From the RA patients and controls, 5-10ml of blood was collected in anticoagulant free test-tubes and left to clot for 30 minutes at room temperature. Blood samples were then centrifuged at 3000 G for 15 minutes at 4 o C.
The sera were then separated and stored at - It was not possible to obtain SF levels for XO, MDA, CAT, SOD and vitamin E from healthy participants (controls). This is because it was determined unethical to obtain SF samples from healthy controls as the procedure is invasive and carries its own risks.
Measurement of XO
The serum and SF levels of XO were measured using spectrophotometry by calculating the increase in absorbance at 293 nm through the formation of uric acid from xanthine using Prajda N 1975 method [31] . 
Measurement of MDA
The serum and SF levels of MDA were measured using the Ohkawa et al 1970 method [32] . Fluorometry was used to measure 2-thiobarbituric acid (TBA). Results were expressed in nmol/ml.
Measurement of CAT
The serum and SF levels of catalase were measured usingthe Abei Kinetic method [33] .
The activity of catalase was measured spectrophotometrically by measuring the degradation of H 2 O 2 . Results were expressed in IU/L.
Measurement of SOD
The serum and SF levels of SOD were measured using the Sun et al 1988method [34] . The reduction of Nitrobluetetrazolium (NBT) was inhibited by oxygen generated from xanthine/ xanthine oxidase. The amount of enzyme causing 50% NBT inhibition reduction rate was considered as one unit of SOD activity. Results were expressed in U/ml.
Measurement of vitamin E
The serum and SF levels of vitamin E (αtocopherol) were measured using the Baker and Frank 1980 method [35] . Ferrous ions were reduced forming a red complex with α-α1 dipyridyl and measured. Results were expressed in mg/dl.
Statistical analysis
Statistical Package for the Social Sciences proportion of the total ROS produced naturally [44] . Previous studies agree that oxidative stress is increased in the serum and SF of RA patients however, conflicting results were found regarding serum and SF antioxidant levels, with some authors reporting an increase while others reporting a decrease or no activity [28, 43, 59, 60] reducing the SF levels of SOD lower than the serum.
RESULTS

As shown in
One important byproduct of SOD activity is hydrogen peroxide which needs to be detoxified by catalase and other enzymes. Documented improvement in disease progression using antioxidants demonstrates the importance of antioxidants in reducing oxidative stress [70, 71] . Furthermore, the increase in serum and SF levels of XO observed in this study suggest that XO inhibitors could be used as therapeutic agents in RA patients to reduce inflammation.
Further research is needed to reveal the therapeutic potential of oxidants and antioxidants in managing RA.
CONCLUSION
In conclusion, our current study demonstrates that RA patients experience heightened [52] Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4(9), 1990, 2587-2597.
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